Magrath George 4
4 · Opus Genetics, Inc. · Filed Apr 27, 2026
Research Summary
AI-generated summary of this filing
Opus Genetics CEO George Magrath Sells 9,511 Shares
What Happened George Magrath, CEO of Opus Genetics (IRD), had 9,511 shares sold on April 23, 2026 at $5.22 per share, generating proceeds of $49,647. The sale was recorded as an open market/private sale (S) but was executed automatically by the company to cover tax withholding from a restricted stock unit (RSU) vesting and settlement — not a discretionary trade by the CEO.
Key Details
- Transaction date and price: 2026-04-23, 9,511 shares at $5.22, total $49,647.
- Reason/footnote: Automatic sale to satisfy tax withholding obligations related to RSU vesting (Footnote F1).
- Shares owned after transaction: Not disclosed in the filing.
- Filing: Form 4 filed 2026-04-27; filing appears timely (filed within required business-day window).
Context Tax-withholding sales after RSU vesting are routine and do not necessarily indicate the insider’s view on the company’s prospects, since the sale is to cover taxes rather than a discretionary liquidation. For retail investors, purchases tend to be more informative about insider sentiment; this automatic sale should be viewed as a routine administrative action unless accompanied by additional discretionary trades.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-04-23$5.22/sh−9,511$49,647→ 1,741,344 total
Footnotes (1)
- [F1]The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.